← back to search

Hafid Ait‐Oufella

Nantes Université ·
Area of research
Epidemiology · Immunology
Research interest
Research interests include Atherosclerosis and Cardiovascular Diseases, Sepsis Diagnosis and Treatment, Hemodynamic Monitoring and Therapy, and COVID-19 Clinical Research Studies.
h-index
59
citations
13,513
works
329
NIH funding
primary concept
Medicine
email

Recent publications

Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind, Randomized Controlled Trial
American Journal of Respiratory and Critical Care Medicine 2025cited by 6position: middledoi
Region-specific gene expression and sex inform about disease susceptibility in the aorta
Nature Cardiovascular Research 2025cited by 4position: middledoi
Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis
Nature 2024cited by 70position: middledoi
Community-acquired Klebsiella pneumoniae pneumonia in ICU: a multicenter retrospective study
Annals of Intensive Care 2024cited by 12position: middledoi
Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU)
Intensive Care Medicine 2023cited by 68position: middledoi
Prognostic value of capillary refill time in adult patients: a systematic review with meta-analysis
Critical Care 2023cited by 27position: middledoi
Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy
Nature Communications 2023cited by 25position: lastdoi
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
The Lancet Infectious Diseases 2022cited by 20position: middledoi
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
The Lancet Infectious Diseases 2021cited by 343position: middledoi
Endothelial Responses in Sepsis
American Journal of Respiratory and Critical Care Medicine 2020cited by 695position: lastdoi
Management and prevention of anemia (acute bleeding excluded) in adult critical care patients
Annals of Intensive Care 2020cited by 62position: middledoi
MHC Class II–Restricted Antigen Presentation by Plasmacytoid Dendritic Cells Drives Proatherogenic T Cell Immunity
Circulation 2014cited by 92position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

M. Luisa Iruela‐Arispe · Northwestern University1 papers (2025–2025)Nathalie Gault · French Clinical Research Infrastructure Network1 papers (2024–2024)Gianluca Grassia · University of Naples Federico II1 papers (2014–2014) · 1 papers (2020–2020)Judith Hellman · City College of San Francisco1 papers (2020–2020)Andrew L. Wang · New York University1 papers (2025–2025)Leanne Masters · University of Cambridge1 papers (2014–2014)Rémi Schweizer · University of Lausanne1 papers (2023–2023)Bhama Ramkhelawon · NYU Langone Health1 papers (2025–2025)Stéphanie Hugues · University of Geneva1 papers (2014–2014)Jocelynda Salvador · Northwestern University1 papers (2025–2025) · 1 papers (2024–2024)Ana Mompeón · Northwestern University1 papers (2025–2025)Jérémie Joffre · Inserm1 papers (2020–2020) · 1 papers (2024–2024)Gloria E. Hernandez · Northwestern University1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2023–2023)Pasquale Maffia · University of Glasgow1 papers (2014–2014)Ziad Mallat · Inserm1 papers (2014–2014)